| 1 |
33705753 | MYC-Mediated Ribosomal Gene Expression Sensitizes Enzalutamide-resistant Prostate Cancer Cells to EP300/CREBBP Inhibitors. | 2021 Jun |
2 |
| 2 |
32313135 | Pharmacological and genetic targeting of 5-lipoxygenase interrupts c-Myc oncogenic signaling and kills enzalutamide-resistant prostate cancer cells via apoptosis. | 2020 Apr 20 |
3 |
| 3 |
30820039 | A positive role of c-Myc in regulating androgen receptor and its splice variants in prostate cancer. | 2019 Jun |
2 |
| 4 |
30940724 | NOTCH signaling is activated in and contributes to resistance in enzalutamide-resistant prostate cancer cells. | 2019 May 24 |
2 |
| 5 |
31747605 | CREB5 Promotes Resistance to Androgen-Receptor Antagonists and Androgen Deprivation in Prostate Cancer. | 2019 Nov 19 |
1 |
| 6 |
26056150 | NF-κB2/p52:c-Myc:hnRNPA1 Pathway Regulates Expression of Androgen Receptor Splice Variants and Enzalutamide Sensitivity in Prostate Cancer. | 2015 Aug |
2 |